Linamet ER Tablet is a fixed-dose combination of Linagliptin and Metformin Hydrochloride (Extended Release) used in the management of type 2 diabetes mellitus. It is prescribed for patients whose blood glucose levels are not adequately controlled with diet, exercise, or monotherapy.
The extended-release (ER) formulation of Metformin provides sustained drug release, improving gastrointestinal tolerance and ensuring better glycemic control throughout the day.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Composition
-
Active Ingredients: Linagliptin + Metformin Hydrochloride (ER)
-
Strength: 2.5 mg + 1000 mg
-
Dosage Form: Extended-release oral tablet
Mechanism of Action
This combination works through complementary pathways:
Linagliptin:
-
Inhibits the DPP-4 enzyme
-
Increases incretin hormones (GLP-1 and GIP)
-
Enhances glucose-dependent insulin secretion
-
Reduces glucagon secretion from the liver
Metformin (ER):
-
Reduces hepatic glucose production
-
Improves insulin sensitivity in peripheral tissues
-
Decreases intestinal absorption of glucose
-
Extended-release form provides gradual drug release and better tolerability
Together, they provide effective 24-hour glycemic control.
Indications
Linamet ER Tablet is indicated for:
-
Type 2 diabetes mellitus
-
Patients inadequately controlled on Metformin alone
-
Patients requiring combination therapy for improved glycemic control
-
Adjunct to diet and exercise in adult diabetic patients
Dosage and Administration
-
Dosage is individualized based on patient response and blood glucose levels
-
Usually taken once daily with the evening meal
-
Swallow whole; do not crush or chew (ER formulation)
-
Regular monitoring of blood glucose is required
-
Dose adjustment may be needed in renal impairment
Benefits
-
Dual mechanism for effective blood sugar control
-
Extended-release Metformin reduces gastrointestinal side effects
-
Improves fasting and post-meal glucose levels
-
Convenient once-daily dosing
-
Low risk of hypoglycemia when used alone
-
Supports long-term diabetes management
Side Effects
Common side effects may include:
-
Nausea or vomiting
-
Diarrhea (less frequent with ER formulation)
-
Abdominal discomfort
-
Headache
-
Nasopharyngitis
Less common but serious effects:
-
Lactic acidosis (rare, associated with Metformin)
-
Pancreatitis (rare, associated with Linagliptin)
-
Hypoglycemia (mainly when combined with insulin or sulfonylureas)
-
Allergic reactions
Precautions and Warnings
-
Use only under medical supervision
-
Monitor renal function regularly
-
Avoid excessive alcohol intake (risk of lactic acidosis)
-
Temporarily discontinue before contrast imaging procedures if advised
-
Not suitable for type 1 diabetes or diabetic ketoacidosis
-
Do not crush or chew ER tablets
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Use in Special Populations
-
Pregnancy: Insulin is preferred; use only if prescribed
-
Lactation: Consult physician before use
-
Pediatrics: Not recommended
-
Elderly: Requires careful monitoring and renal dose adjustment
Storage
-
Store below 25°C
-
Protect from moisture and light
-
Keep in original packaging
-
Keep out of reach of children.